key: cord-0841613-ikqsb5bd authors: Aoki, Akira; Adachi, Hirokazu; Mori, Yoko; Ito, Miyabi; Sato, Katsuhiko; Okuda, Kenji; Sakakibara, Toru; Okamoto, Yoshinori; Jinno, Hideto title: Discrimination of SARS-CoV-2 Omicron sub-lineages BA.1 and BA.2 using a high-resolution melting-based assay: A pilot study date: 2022-04-12 journal: bioRxiv DOI: 10.1101/2022.04.11.487970 sha: 4a53c947cc88ca35efc423fb4b8f89388db9347e doc_id: 841613 cord_uid: ikqsb5bd The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide. As of March 2022, Omicron variant BA.2 is rapidly replacing variant BA.1. As variant BA.2 may cause more severe disease than variant BA.1, variant BA.2 requires continuous monitoring. The current study aimed to develop a novel high-resolution melting (HRM) assay for variants BA.1 and BA.2 and to determine the sensitivity and specificity of our method using clinical samples. Here, we focused on the mutational spectra at three regions in the spike receptor-binding domain (RBD; R408, G446/L452, and S477/T478) for the variant-selective HRM analysis. Each variant was identified based on the mutational spectra as follows: no mutations (Alpha variant); L452R and T478K (Delta variant); G446S and S477N/T478K (Omicron variant BA.1); and R408S and S477N/T478K (Omicron variant BA.2). Upon analysis of mutation-coding RNA fragments, the melting peaks of the wild-type fragments were distinct from those of the mutant fragments. The sensitivity and specificity of this method were determined as 100% and more than 97.5%, respectively, based on 128 clinical samples (40 Alpha, 40 Delta, 40 Omicron variants BA.1/BA.1.1, and 8 Omicron BA.2). These results suggest that this HRM-based assay is a promising screening method for monitoring the transmission of Omicron variants BA.1 and BA.2. Japan (17, 18). Whole-genome sequencing was performed using a next-generation sequencer (MiSeq system; Illumina Inc., San Diego, CA, USA). The obtained NGS reads were mapped to the SARS-CoV-2 Wuhan-Hu-1 159 reference genome sequence (29.9 kb single-strand RNA; GenBank ID: sample and one Delta sample plot disagreed with each positive control plot (Fig. 198 3). Therefore, we calculated the sensitivity and specificity of the current 199 HRM-based assay based on these results. The sensitivity and specificity of the 200 assay for the three regions were 100% and over 97.5%, respectively (Table 4) . However, the HRM assay may not be able to identify samples that contain low virus copies. Our previous study showed that when used with samples 230 containing >10 7 copies/mL, the HRM assay could detect SARS-CoV-2 mutations 231 (21). In this study, the two-step nested PCR improved the detection limit of the 232 HRM assay, and low-copy virus samples could be identified, such as those Genetics and genomics of 277 A review of the literature with the special focus on genetic 278 diversity and SARS-CoV-2 genome detection The global epidemic of SARS-CoV-2 280 variants and their mutational immune escape Collaboration between clinical and academic 340 laboratories for sequencing SARS-CoV-2 genomes Simultaneous screening of 343 SARS-CoV-2 omicron and Delta variants using high-resolution melting 344 analysis A rapid screening assay for L452R and T478K spike 347 mutations in SARS-CoV-2 Delta variant using high-resolution melting 348 analysis A proposal of 350 an alternative primer for the ARTIC Network's multiplex PCR to improve 351 nCoV-2019 sequencing protocol for Illumina Global spread of a Japan-originated Delta 358 lineage of SARS-CoV-2 after the Tokyo Olympics is most likely unrelated 359 to the Olympics Reduced risk of 363 hospitalisation among reported COVID-19 cases infected with the 364 SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant Development of a genotyping 367 platform for SARS-CoV-2 variants using high-resolution melting analysis A screening strategy for identifying the dominant variant 371 of SARS-COV-2 in the fifth peak of Kurdistan-Iran population using HRM 372 and probe-based RT-PCR assay